Notice for S1-RBD-sFc and Th/CTL peptides (Graython Regulatory Services Pty Ltd)
Active ingredients
S1-RBD-sFc and Th/CTL peptides
Date of review outcome
Lapse date
Type
Provisional determination
Indication
Booster immunization in people who have received a primary immunization with another COVID-19 vaccine (i.e., mRNA, adeno-vectored, inactivated whole virus) to prevent COVID-19 caused by SARS-CoV-2 in individuals 16 years of age and older
Therapeutic area
Infectious diseases